Scientists at the Icahn School of Medicine at Mount Sinai have uncovered a surprising genetic connection between two very different diseases: inflammatory bowel disease (IBD) and Parkinson’s disease (PD). This discovery, published on May 14 in Genome Medicine, could one day lead to treatments that work on both conditions at the same time.
IBD is a condition that causes long-term inflammation of the digestive tract. It makes everyday eating and digestion painful and difficult. On the other hand, Parkinson’s disease affects the brain, causing problems with movement, balance, and even memory. Although these two illnesses seem very different at first glance, the new study shows that they may share some common genetic roots.
The research team, led by Dr. Meltem Ece Kars along with Dr. Yuval Itan and Dr. Inga Peter, used modern methods to look at the DNA of people with these diseases. They focused on finding rare changes in the genes that could explain why some people suffer from both IBD and PD.
One of the most important findings was that changes in a gene called LRRK2 appeared in many people with both conditions. This gene was already known to be linked with Parkinson’s disease, but its connection with IBD is a newer discovery.
The study did not just stop at looking for changes in LRRK2. The researchers also found other genes that might be involved when someone has both IBD and PD.
By looking at data from several large groups of people—such as those from the Mount Sinai BioMe BioBank, the UK Biobank, and even a group of 67 patients from the Danish National Biobank—they were able to get a much clearer picture of the genetic landscape. This large set of information allowed them to focus on rare but important genetic changes that might have been missed in smaller studies.
For people who are not familiar with the terms, genes are like instructions that tell our bodies how to work. When there is a change or a mutation in a gene, it can sometimes lead to problems in the body.
In this case, the mutation in the LRRK2 gene seems to affect both the gut and the brain, suggesting that the two conditions might actually be linked at the very basic level of our DNA.
The researchers used computer programs and special techniques to sort through the vast amounts of genetic data. One method, called network-based heterogeneity clustering, helped them find patterns in small groups of patients.
This method is useful when traditional ways of studying genes do not work well because the group of patients is too small or the changes in the genes are very rare.
The study also highlighted several biological pathways—these are like roads in the body that help signals travel from one cell to another.
The pathways involved in immunity, inflammation, and autophagy (which is the process of cleaning up and recycling damaged cells) all played a role in both IBD and PD. This means that the way our bodies handle inflammation and clean out old or damaged parts of our cells might be a key factor in both diseases.
These findings are exciting because they open the door to new ideas for treatment. If doctors and researchers can find ways to fix or adjust these common genetic pathways, they might be able to create therapies that help both people with IBD and those with Parkinson’s disease. This could mean that in the future, a single treatment might be able to slow down or even prevent the progress of both conditions.
Looking at the study as a whole, the work done by the team at Mount Sinai shows a promising connection between two diseases that were once thought to be unrelated. The use of advanced genetic analysis has allowed scientists to see that changes in certain genes, like LRRK2, can affect different parts of the body in ways that lead to serious illness.
While more research is needed to fully understand how these genetic changes cause disease, the study offers hope that targeted treatments could be developed.
In the end, the discovery of this genetic link may help lead to better ways to treat or even prevent both inflammatory bowel disease and Parkinson’s disease, offering new hope to patients who suffer from these challenging conditions.
The research findings can be found in Genome Medicine.
Copyright © 2025 Knowridge Science Report. All rights reserved.
